![Daniel F. Voytas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel F. Voytas
Corporate Officer/Principal bij
University of Minnesota
Profiel
Daniel F.
Voytas was the founder of Calyxt, Inc. which was founded in 2010, where he held the title of Chief Science Officer from 2010 to 2021.
Currently, he is the Director-Center for Precision Plant Genomics at the University of Minnesota since 2008.
Dr. Voytas received his doctorate degree from Harvard Medical School in 1990 and his undergraduate degree from Harvard College in 1984.
Actieve functies van Daniel F. Voytas
| Bedrijven | Functie | Begin |
|---|---|---|
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2008 |
Eerdere bekende functies van Daniel F. Voytas
| Bedrijven | Functie | Einde |
|---|---|---|
Calyxt, Inc.
 Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage biotechnology company, engages in development and commercialization of products derived from plant cells | Oprichter | 01-02-2021 |
Opleiding van Daniel F. Voytas
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
97
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calyxt, Inc.
Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage biotechnology company, engages in development and commercialization of products derived from plant cells | Commercial Services |
